Evidence map›Paper›PMID 31545294›Full record

ArticleAging2019

Sulfated polysaccharide of

Liping Shan, Wei Liu, Yunhong Zhan

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Polysaccharides fromCurrent medicinal chemistry · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Liping ShanDepartment of Urology, Shengjing Hospital, China Medical University, Shenyang, Liaoning 110004, China.
Wei LiuEmergency Department, First Hospital of China Medical University, Shenyang, Liaoning, China.
Yunhong ZhanDepartment of Urology, Shengjing Hospital, China Medical University, Shenyang, Liaoning 110004, China.
China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid appearance of resistance to fibroblast growth factor receptor (FGFR) inhibitors hampers targeted regimens in bladder cancer. In the present study, we evaluated whether SIP-SII, a sulphated derivative of the polysaccharide in

Indexed as

DecapodiformesAnimalsAntineoplastic AgentsApoptosisBenzamidesCell CycleCell Line, TumorCell MovementDrug Resistance, NeoplasmInkPhosphorylationPiperazinesPolysaccharidesProto-Oncogene Proteins c-aktPyrazolesReceptors, Fibroblast Growth FactorAntineoplastic AgentsAZD4547BenzamidesPiperazinesPolysaccharidesProto-Oncogene Proteins c-aktPyrazolesReceptors, Fibroblast Growth FactorAZD4547bladder cancerFGFR therapy resistanceSulfated polysaccharide of ink Sepiella maindronixenograft

Identifiers

PMID31545294
PMCPMC6782013
OpenAlexW2975412495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.